Seeking AlphaTue, 30 Jun 2026 18:32:38 GMTViking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s AccelerateVKTX-2.71%
Zacks Investment ResearchMon, 29 Jun 2026 14:31:10 GMTIs It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?VKTX-2.71%
The Motley FoolFri, 26 Jun 2026 15:05:48 GMTDyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?VKTX-2.71%
Zacks Investment ResearchThu, 25 Jun 2026 22:45:39 GMTViking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to KnowVKTX-2.71%
Zacks Investment ResearchThu, 25 Jun 2026 15:01:18 GMTVKTX Stock Jumps on Phase I Study Initiation for New Obesity DrugVKTX-2.71%
The Motley FoolTue, 23 Jun 2026 04:30:00 GMTIs Viking Therapeutics Stock a No-Brainer Buy Below $35?VKTX-2.71%
Zacks Investment ResearchWed, 17 Jun 2026 22:50:22 GMTViking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should KnowVKTX-2.71%
Zacks Investment ResearchWed, 10 Jun 2026 22:50:18 GMTViking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to KnowVKTX-2.71%
The Motley FoolWed, 10 Jun 2026 17:27:00 GMTWhy 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%VKTX-2.71%
Zacks Investment ResearchThu, 04 Jun 2026 22:45:30 GMTViking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to ConsiderVKTX-2.71%
Seeking AlphaThu, 04 Jun 2026 19:32:55 GMTViking Therapeutics, Inc. (VKTX) Presents at Jefferies Global Healthcare Conference 2026 TranscriptVKTX-2.71%
The Motley FoolWed, 03 Jun 2026 10:49:00 GMTBull vs. Bear: The Quick Take on Viking Therapeutics StockVKTX-2.71%
The Motley FoolTue, 02 Jun 2026 14:48:00 GMTViking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside DownVKTX-2.71%
Zacks Investment ResearchFri, 29 May 2026 16:31:56 GMTWhy Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?VKTX-2.71%
Zacks Investment ResearchThu, 28 May 2026 22:46:05 GMTViking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to ConsiderVKTX-2.71%
The Motley FoolTue, 26 May 2026 00:00:00 GMTDon't Buy Viking Therapeutics Stock Until You Read ThisVKTX-2.71%
Seeking AlphaTue, 05 May 2026 16:00:22 GMTViking Therapeutics: Market Betting On Big Upside Through 2030VKTX-2.71%
MarketBeatFri, 01 May 2026 14:45:56 GMTViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeVKTX-2.71%
